摘要
溃疡性结肠炎(UC)是一种主要影响结肠和直肠的炎症性肠病(IBD)。它的主要特征包括黏膜炎症的复发和缓解,从直肠开始,典型地持续向近端延伸,通过部分或整个结肠。UC的发病取决于多种因素,如遗传易感性、上皮屏障缺陷、免疫反应失调和环境原因。最常见的症状是腹痛、体重减轻、粘液排出、带血腹泻、失禁、夜间排便、发烧和贫血。目前UC的治疗包括5-氨基水杨酸(5-ASA)及其衍生物、类固醇、免疫抑制剂和生物药物。然而,有限的疗效和不必要的副作用很难限制这些治疗策略。在过去的几十年里,研究已经推动了补充和替代药物治疗UC。各种营养药物在调节肠道炎症、改善症状方面表现出了良好的效果。体外研究证明,这些化合物具有广泛的积极健康作用,其特征是参与抗氧化防御、细胞增殖和基因表达。本综述分析了现有的关于不同类型的保健品及其作为IBD辅助治疗的潜在疗效的数据,特别是UC。
关键词: 溃疡性结肠炎、炎症性肠病、营养品、姜黄素、柚皮素、橄榄苦苷。
Current Medicinal Chemistry
Title:The Significant Role of Nutraceutical Compounds in Ulcerative Colitis Treatment
Volume: 29 Issue: 24
关键词: 溃疡性结肠炎、炎症性肠病、营养品、姜黄素、柚皮素、橄榄苦苷。
摘要: Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) mainly affecting the colon and the rectum. Its main characteristics include relapsing and remitting mucosal inflammation, starting in the rectum and typically extending continuously proximally through part of or the entire colon. UC pathogenesis depends on multiple factors, such as genetic predisposition, defects in the epithelial barrier, dysregulated immune responses, and environmental causes. The most frequent symptoms are abdominal pain, weight loss, mucus discharge, bloody diarrhoea, incontinence, nocturnal defecations, fever, and anemia. Existing therapies for UC include 5-aminosalicylic acid (5-ASA) and its derivatives, steroids, immunosuppressants, and biological drugs. However, limited efficacy and unwanted adverse effects hardly limit these strategies of treatment. In the last decades, research studies have been driven towards complementary and alternative medicines for the treatment of UC. Various nutraceuticals have exhibited promising results in modulating intestinal inflammation while improving symptoms. These compounds possess a wide spectrum of positive health effects evidenced by in vitro studies, characterized by their involvement in antioxidant defenses, cell proliferation, and gene expression. The present review analyzes the available data about the different types of nutraceuticals and their potential effectiveness as adjuvant therapy of IBD, with particular emphasis to UC.
Export Options
About this article
Cite this article as:
The Significant Role of Nutraceutical Compounds in Ulcerative Colitis Treatment, Current Medicinal Chemistry 2022; 29 (24) . https://dx.doi.org/10.2174/0929867329666211227121321
DOI https://dx.doi.org/10.2174/0929867329666211227121321 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cationic Liposomes as Non-viral Vector for RNA Delivery in Cancer Immunotherapy
Recent Patents on Drug Delivery & Formulation Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Current Drug Targets Naphthoflavones as Antiproliferative Agents: Design, Synthesis and Biological Evaluation
Anti-Cancer Agents in Medicinal Chemistry Overlapping Ligand Specificity of P-Glycoprotein and Serum α1-Acid Glycoprotein:Evidences and Potential Implications
Current Drug Metabolism Novel Functions and Binding Mechanisms of Carbohydrate-Binding Proteins Determined by Force Measurements
Current Protein & Peptide Science Multi-output Model with Box-Jenkins Operators of Quadratic Indices for Prediction of Malaria and Cancer Inhibitors Targeting Ubiquitin- Proteasome Pathway (UPP) Proteins
Current Protein & Peptide Science Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Impact of Physicochemical Parameters on Effective Extraction of Bioactive Compounds from Natural Sources: An Overview
Current Bioactive Compounds Single-Molecule Spectroscopy for Nucleic Acid Analysis: A New Approach for Disease Detection and Genomic Analysis
Current Pharmaceutical Biotechnology Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Current Pharmaceutical Biotechnology Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma
Combinatorial Chemistry & High Throughput Screening Feature Based Fusion of Multimodal Medical Image Slices with Combined Transforms
Current Medical Imaging Synthesis and Evaluation of Benzimidazole Derivatives as Selective COX-2 Inhibitors
Medicinal Chemistry Alzheimer’s Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration
Current Molecular Pharmacology Stability and Drug Metabolism Assessed by Electrochemical Methods
Combinatorial Chemistry & High Throughput Screening α7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era
Current Drug Targets Potential Therapeutic Relevance of CRISPR/Cas9 Guided Epigenetic Regulations for Neuropsychiatric Disorders
Current Topics in Medicinal Chemistry Advances in Characterization of Human Sirtuin Isoforms: Chemistries, Targets and Therapeutic Applications
Current Medicinal Chemistry A Guide to Template Based Structure Prediction
Current Protein & Peptide Science A Review on Pharmacological and Clinical Aspects of Linum usitatissimum L.
Current Drug Discovery Technologies